Header Logo

Jonathan Gerber

Concepts (235)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
8
2025
170
2.640
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
2021
68
1.570
Why?
Immunization, Passive
9
2024
99
1.050
Why?
Myelodysplastic Syndromes
2
2025
74
0.930
Why?
Antibodies, Bispecific
2
2023
29
0.930
Why?
Dioxygenases
1
2024
25
0.890
Why?
Neoplastic Stem Cells
4
2013
203
0.880
Why?
Urticaria
1
2023
7
0.870
Why?
Mutation
5
2025
2466
0.850
Why?
Transfusion Reaction
1
2023
46
0.850
Why?
Lymphadenopathy
1
2021
23
0.730
Why?
Positron Emission Tomography Computed Tomography
1
2021
42
0.720
Why?
Stem Cell Transplantation
2
2020
74
0.700
Why?
Hematopoietic Stem Cell Transplantation
4
2024
329
0.640
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2020
406
0.630
Why?
Vaccination
1
2021
342
0.610
Why?
DNA-Binding Proteins
1
2024
1142
0.580
Why?
Leukemia
2
2016
54
0.530
Why?
Paraneoplastic Syndromes
1
2016
12
0.520
Why?
Antigens, CD34
3
2017
53
0.510
Why?
Humans
43
2025
60079
0.510
Why?
Neoplasms
3
2023
1262
0.480
Why?
Phenotype
2
2016
1145
0.470
Why?
Antineoplastic Agents
2
2020
646
0.470
Why?
Chromosome Aberrations
1
2014
62
0.450
Why?
Stem Cells
2
2013
258
0.440
Why?
Hematopoietic Stem Cells
3
2013
275
0.440
Why?
Transplantation Conditioning
2
2024
94
0.380
Why?
Skin Neoplasms
1
2016
405
0.360
Why?
Disease Progression
4
2024
1053
0.360
Why?
Biomarkers
1
2016
1214
0.360
Why?
Outpatients
4
2024
140
0.350
Why?
Leukemia, Promyelocytic, Acute
2
2020
18
0.310
Why?
Adult
14
2025
15971
0.300
Why?
Cytarabine
2
2020
34
0.300
Why?
Aged
12
2025
13595
0.290
Why?
Middle Aged
12
2025
16541
0.270
Why?
Male
17
2025
27950
0.270
Why?
Female
18
2025
31225
0.260
Why?
Antibodies, Viral
2
2024
302
0.240
Why?
Prognosis
4
2025
1591
0.230
Why?
DNA (Cytosine-5-)-Methyltransferases
1
2024
28
0.230
Why?
Staurosporine
1
2024
19
0.220
Why?
Core Binding Factor Alpha 2 Subunit
1
2024
83
0.220
Why?
Graft vs Host Disease
1
2024
103
0.220
Why?
Chromosomal Proteins, Non-Histone
1
2025
168
0.220
Why?
Protein Kinase Inhibitors
1
2024
171
0.200
Why?
Cell Cycle Proteins
1
2025
388
0.200
Why?
Proto-Oncogene Proteins
1
2024
317
0.200
Why?
Repressor Proteins
1
2024
337
0.190
Why?
Blast Crisis
1
2021
10
0.190
Why?
ADP-ribosyl Cyclase 1
2
2012
29
0.190
Why?
Genes, p53
1
2021
53
0.190
Why?
Fluorodeoxyglucose F18
1
2021
80
0.180
Why?
Aged, 80 and over
4
2025
5200
0.180
Why?
Radiopharmaceuticals
1
2021
172
0.170
Why?
Tretinoin
3
2017
49
0.170
Why?
Diagnosis, Differential
2
2021
908
0.170
Why?
Anthracyclines
1
2020
10
0.170
Why?
Mice, SCID
2
2012
509
0.170
Why?
Allografts
1
2020
45
0.170
Why?
Cytochrome P-450 CYP2C19
1
2019
6
0.170
Why?
Mice, Inbred NOD
2
2012
516
0.170
Why?
Voriconazole
1
2019
6
0.170
Why?
Invasive Fungal Infections
1
2019
6
0.170
Why?
Randomized Controlled Trials as Topic
1
2023
685
0.170
Why?
Hospitalization
2
2024
1304
0.160
Why?
Tumor Suppressor Protein p53
1
2021
300
0.160
Why?
United States Food and Drug Administration
1
2020
95
0.160
Why?
Cytochrome P-450 CYP3A
1
2018
11
0.160
Why?
Antifungal Agents
1
2019
116
0.160
Why?
Tacrolimus
1
2018
39
0.160
Why?
Immunophenotyping
2
2016
185
0.160
Why?
Bone Marrow
3
2016
177
0.160
Why?
Antibodies, Monoclonal, Humanized
1
2020
225
0.150
Why?
Hematologic Neoplasms
2
2024
45
0.150
Why?
United States
5
2023
7622
0.150
Why?
Polymorphism, Genetic
1
2018
191
0.150
Why?
Telemedicine
1
2023
337
0.150
Why?
Myelopoiesis
1
2017
14
0.140
Why?
Double-Blind Method
3
2024
684
0.140
Why?
Immunosuppressive Agents
1
2018
304
0.140
Why?
Receptors, Colony-Stimulating Factor
1
2016
1
0.140
Why?
Leukemia, Neutrophilic, Chronic
1
2016
4
0.140
Why?
Signal Transduction
4
2017
2892
0.130
Why?
Germ-Line Mutation
1
2016
46
0.130
Why?
Arabinonucleosides
1
2016
2
0.130
Why?
Adenine Nucleotides
1
2016
4
0.130
Why?
Mastocytosis
1
2016
2
0.130
Why?
Skin Diseases, Bacterial
1
2016
5
0.130
Why?
Etoposide
1
2016
35
0.130
Why?
Karyotyping
1
2016
43
0.130
Why?
Dermatomycoses
1
2016
13
0.130
Why?
Leukopenia
1
2016
16
0.130
Why?
Niacinamide
1
2016
32
0.130
Why?
Phenylurea Compounds
1
2016
30
0.130
Why?
Cell Differentiation
4
2017
1298
0.130
Why?
Lymph Nodes
2
2013
215
0.130
Why?
Glycoproteins
1
2017
192
0.120
Why?
In Situ Hybridization, Fluorescence
1
2016
152
0.120
Why?
Mutation, Missense
1
2016
178
0.120
Why?
Multiple Myeloma
1
2020
324
0.120
Why?
Young Adult
4
2025
4398
0.120
Why?
Severity of Illness Index
1
2020
1471
0.120
Why?
Bone Marrow Cells
1
2016
232
0.120
Why?
Down-Regulation
2
2013
306
0.120
Why?
Cell Proliferation
3
2013
944
0.120
Why?
Kaplan-Meier Estimate
1
2016
391
0.120
Why?
Neutrophils
1
2017
352
0.110
Why?
Tissue Donors
2
2024
134
0.110
Why?
Automation, Laboratory
1
2013
7
0.110
Why?
Mice
6
2013
10317
0.110
Why?
Lymphoma, Follicular
1
2013
15
0.110
Why?
Ki-67 Antigen
1
2013
34
0.110
Why?
Splenic Rupture
1
2013
2
0.110
Why?
Sarcoma, Myeloid
1
2013
4
0.110
Why?
Cyclin D1
1
2013
21
0.110
Why?
Bone Morphogenetic Protein Receptors
1
2013
14
0.110
Why?
Recurrence
2
2012
600
0.110
Why?
Translocation, Genetic
1
2013
63
0.110
Why?
Chemokine CCL2
1
2013
54
0.110
Why?
Transplantation, Autologous
2
2024
120
0.100
Why?
Tumor Cells, Cultured
1
2013
453
0.100
Why?
Treatment Outcome
5
2024
5266
0.100
Why?
Transforming Growth Factor beta
1
2013
161
0.100
Why?
Up-Regulation
1
2013
365
0.100
Why?
Neoplasm, Residual
1
2012
35
0.100
Why?
Bone Marrow Transplantation
1
2012
134
0.100
Why?
Cells, Cultured
2
2017
2095
0.100
Why?
Cell Separation
1
2012
146
0.090
Why?
Cytosine
1
2011
31
0.090
Why?
DNA Repair
1
2013
236
0.090
Why?
WT1 Proteins
1
2011
6
0.090
Why?
Carcinoma, Ductal, Breast
1
2011
47
0.090
Why?
Myeloblastin
1
2011
14
0.090
Why?
Aldehyde Dehydrogenase
1
2011
13
0.090
Why?
Inhibitor of Apoptosis Proteins
1
2011
38
0.090
Why?
Telomerase
1
2011
30
0.090
Why?
Neoplasm Transplantation
1
2011
160
0.090
Why?
Microtubule-Associated Proteins
1
2011
109
0.090
Why?
Antigens, Neoplasm
1
2011
136
0.090
Why?
Transcriptome
1
2013
337
0.080
Why?
Prospective Studies
3
2023
3132
0.080
Why?
Gene Expression Profiling
1
2013
713
0.080
Why?
Cytokines
2
2023
911
0.080
Why?
Animals
6
2013
19739
0.080
Why?
Colonic Neoplasms
1
2011
216
0.080
Why?
Adolescent
3
2024
5944
0.080
Why?
Hodgkin Disease
1
2009
56
0.080
Why?
Adenocarcinoma
1
2011
329
0.080
Why?
Antibodies, Monoclonal
2
2023
853
0.080
Why?
Mice, Transgenic
1
2012
1224
0.080
Why?
Prostatic Neoplasms
1
2011
330
0.070
Why?
Pandemics
2
2023
628
0.070
Why?
Cell Movement
1
2009
426
0.070
Why?
B-Lymphocytes
1
2009
552
0.060
Why?
RNA, Messenger
1
2011
1465
0.060
Why?
Transplantation, Haploidentical
1
2024
3
0.060
Why?
HLA Antigens
1
2024
59
0.060
Why?
Blood Donors
1
2024
21
0.060
Why?
Transplantation, Homologous
1
2024
236
0.060
Why?
fms-Like Tyrosine Kinase 3
1
2024
26
0.060
Why?
High-Throughput Nucleotide Sequencing
1
2025
262
0.050
Why?
Interleukin-7
1
2023
30
0.050
Why?
Interleukin-8
1
2023
83
0.050
Why?
Post-Exposure Prophylaxis
1
2023
7
0.050
Why?
Safety-net Providers
1
2023
34
0.050
Why?
Syndrome
1
2023
173
0.050
Why?
Antibodies
1
2023
176
0.050
Why?
Breast Neoplasms
1
2011
1132
0.050
Why?
Antibodies, Neutralizing
1
2024
191
0.050
Why?
Interleukin-6
1
2023
309
0.050
Why?
Immunoglobulin G
1
2024
450
0.050
Why?
Vascular Endothelial Growth Factor A
1
2023
201
0.050
Why?
Spike Glycoprotein, Coronavirus
1
2022
94
0.050
Why?
Sweden
1
2020
42
0.040
Why?
Retrospective Studies
2
2024
6147
0.040
Why?
Ambulatory Care
1
2022
306
0.040
Why?
Universities
1
2020
152
0.040
Why?
Cost Savings
1
2019
56
0.040
Why?
Hemorrhage
1
2020
272
0.040
Why?
Administration, Intravenous
1
2018
61
0.040
Why?
Dose-Response Relationship, Drug
1
2019
806
0.040
Why?
Genotype
1
2019
628
0.040
Why?
HL-60 Cells
1
2017
25
0.030
Why?
Cytochromes c
1
2017
26
0.030
Why?
Neutrophil Activation
1
2017
24
0.030
Why?
Isoleucine
1
2016
9
0.030
Why?
Lactoferrin
1
2017
37
0.030
Why?
Inflammation
1
2023
1111
0.030
Why?
Transforming Growth Factor beta1
1
2017
53
0.030
Why?
Exocytosis
1
2017
59
0.030
Why?
Threonine
1
2016
14
0.030
Why?
Matrix Metalloproteinase 9
1
2017
59
0.030
Why?
Glycosylation
1
2017
133
0.030
Why?
Chromatography, High Pressure Liquid
1
2017
195
0.030
Why?
Disseminated Intravascular Coagulation
1
2016
5
0.030
Why?
Arsenicals
1
2016
7
0.030
Why?
Oxides
1
2016
33
0.030
Why?
Pregnancy
1
2023
2361
0.030
Why?
Tomography, X-Ray Computed
2
2013
1481
0.030
Why?
Amino Acid Substitution
1
2016
250
0.030
Why?
Flow Cytometry
1
2016
638
0.030
Why?
Retinoic Acid 4-Hydroxylase
1
2013
3
0.030
Why?
Retinoic Acid Receptor alpha
1
2013
4
0.030
Why?
Retinal Dehydrogenase
1
2013
6
0.030
Why?
Colony-Forming Units Assay
1
2013
24
0.030
Why?
Cytochrome P-450 Enzyme System
1
2013
26
0.030
Why?
Neoplasm Grading
1
2013
76
0.030
Why?
Chromosomes, Human, Pair 9
1
2013
10
0.030
Why?
Chromosomes, Human, Pair 22
1
2013
10
0.030
Why?
Microarray Analysis
1
2013
58
0.030
Why?
Rupture, Spontaneous
1
2013
22
0.030
Why?
Luciferases
1
2013
109
0.030
Why?
Receptors, Retinoic Acid
1
2013
55
0.030
Why?
Isoenzymes
1
2013
130
0.030
Why?
Induction Chemotherapy
1
2013
33
0.030
Why?
DNA Primers
1
2013
290
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2013
193
0.030
Why?
Protein Binding
1
2017
1571
0.020
Why?
Spleen
1
2013
486
0.020
Why?
Biopsy
1
2013
375
0.020
Why?
5-Methylcytosine
1
2011
20
0.020
Why?
Gestational Age
1
2011
183
0.020
Why?
Drug Resistance, Neoplasm
1
2012
184
0.020
Why?
Embryo, Mammalian
1
2011
161
0.020
Why?
Software
1
2013
376
0.020
Why?
Cell Nucleus
1
2013
605
0.020
Why?
Immunohistochemistry
1
2011
852
0.020
Why?
HEK293 Cells
1
2011
585
0.020
Why?
Reproducibility of Results
1
2013
1565
0.020
Why?
Immunoglobulins
1
2009
76
0.020
Why?
Child
1
2016
4313
0.020
Why?
Cell Line, Tumor
1
2009
1387
0.010
Why?
Mice, Inbred C57BL
1
2011
3215
0.010
Why?
Gerber's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (235)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_